NASDAQ · PRPFX
Permanent Portfolio Permanent I
$75.63-$1.06 (-1.38%)
Permanent Portfolio Permanent I’s quoted price sits in the lower half of its reported 52-week range, 9.63% below the high.
Loading market information…
NASDAQ · SHISX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
BlackRock Health Sciences Opportunities Portfolio Service Shares’s quoted price sits in the upper half of its reported 52-week range, 1.22% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
BlackRock Health Sciences Opportunities Portfolio Service Shares’s forward annual dividend is $12.93 per share, paid semi-annual. The forward yield is 18.64% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
This investment vehicle aims to achieve long-term capital appreciation for its shareholders. It primarily allocates a minimum of 80% of its total assets to equities, predominantly common stock, of companies operating in the health sciences sector and associated industries. This encompasses businesses involved in areas such as healthcare equipment and supplies, service providers, biotechnology, and pharmaceuticals. A key strategy involves concentrating over 25% of its portfolio in these health sciences or related sectors. Furthermore, the fund may invest in companies situated in non-U.S. countries.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 12:50 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$75.63-$1.06 (-1.38%)
Permanent Portfolio Permanent I’s quoted price sits in the lower half of its reported 52-week range, 9.63% below the high.
$30.91-$0.52 (-1.65%)
Fidelity Select Health Care Portfolio’s quoted price sits in the upper half of its reported 52-week range, 1.69% below the high.
$71.21-$1.15 (-1.59%)
ClearBridge International Growth I’s quoted price sits in the lower half of its reported 52-week range, 11.9% below the high.
$76.04+$0.32 (+0.42%)
BlackRock Health Sciences Opportunities Portfolio Class K’s quoted price sits in the upper half of its reported 52-week range, 0.28% below the high.
$75.78+$0.31 (+0.41%)
BlackRock Health Sciences Opportunities Portfolio Institutional Shares’s quoted price sits in the upper half of its reported 52-week range, 0.33% below the high.
$65.52+$0.26 (+0.4%)
BlackRock Health Sciences Opportunities Portfolio’s quoted price sits in the upper half of its reported 52-week range, 1.87% below the high.
$68.92+$0.28 (+0.41%)
BlackRock Health Sciences Opportunities Portfolio Investor A Shares’s quoted price sits in the upper half of its reported 52-week range, 1.27% below the high.
$29.72-$0.26 (-0.87%)
T. Rowe Price Balanced I Class’s quoted price sits in the upper half of its reported 52-week range, 3.07% below the high.
